 SAN FRANCISCO, Oct. 26, 2020 GLOBE NEWSWIRE -- Nurix Therapeutics, Inc. Nasdaq: NRIX, today announced that, based on his desire to lead Nurixs Scientific Advisory Board, Robert Tjian, Ph.D. has resigned from the Companys Board of Directors effective November 1, 2020. Dr. Tjian Tij has served as a member of our Board of Directors since November 2016. Dr. Tjian will continue to provide guidance and advice to Nurix in his new role as Chairman of Nurixs Scientific Advisory Board. 